Inventor · disambiguated record
Laurence Moore
Also filed as: MOORE LAURENCE
1 granted patent·7 pending applications·0 citations·filing 2005–2022
15Inventor score
Top patents by PatentIndex Score
8 records- 0174US2023201155A1Antineoplastic Combinations with m-TOR Inhibitor, Trastuzumab and/or HKI-272WYETH LLC·Filed 2022·Application pending·0 cites
- 0271US2022354820A1Antineoplastic Combinations with m-TOR Inhibitor, Trastuzumab and/or HKI-272WYETH LLC·Filed 2021·Application pending·0 cites
- 0362US10729672B2Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-272WYETH LLC·Filed 2013·Granted Aug 4, 2020·0 cites·14 claims
- 0462US2009297519A1ANTINEOPLASTIC COMBINATIONS WITH mTOR INHIBITOR, TRASTUZUMAB, AND/OR HKI-272WYETH CORP·Filed 2009·Application pending·0 cites
- 0554US2007104721A1Antineoplastic combinations with mTOR inhibitor,herceptin, and/or hki-272WYETH CORP·Filed 2006·Application pending·0 cites
- 0649US2012308560A1Antineoplastic Combinations with mTOR Inhibitor, Trastuzumab and/or HKI-272MOORE LAURENCE·Filed 2012·Application pending·0 cites
- 0733US2005272758A1Antineoplastic combinations of CCI-779 and rituximabWYETH CORP·Filed 2005·Application pending·0 cites
- 0827US2007105887A1Antineoplastic combinations of temsirolimus and sunitinib malateWYETH CORP·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laurence Moore files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →